APOE and metabolic syndrome: ApoE−/− mice are known to exhibit delayed lipoprotein clearance, which contributes to the development of hyperlipidemia or dyslipidemia and ultimately leads to atherosclerosis [49], resembling human pathological conditions [50,51].